Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Behav Pharmacol. 2016 Aug;27(5):415–421. doi: 10.1097/FBP.0000000000000208

Figure 4.

Figure 4

COMT inhibition reverses novel object recognition deficit in COMT-Val transgenic mice. (a) Tolcapone administration produced a significant difference in exploration time between the novel and familiar objects. (b) Tolcapone (30 mg/kg) significantly improved the novel object recognition index compared to vehicle administration in COMT-Val transgenic mice. All data presented as mean ± SEM. n = 6/group; * p < 0.05.